| Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets B Arafat, M Wojsz, A Isreb, RT Forbes, M Isreb, W Ahmed, T Arafat, ... European Journal of Pharmaceutical Sciences 118, 191-199, 2018 | 192 | 2018 |
| Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development B Shriky, A Kelly, M Isreb, M Babenko, N Mahmoudi, S Rogers, ... Journal of colloid and interface science 565, 119-130, 2020 | 166 | 2020 |
| 3D printed oral theophylline doses with innovative ‘radiator-like’design: Impact of polyethylene oxide (PEO) molecular weight A Isreb, K Baj, M Wojsz, M Isreb, M Peak, MA Alhnan International journal of pharmaceutics 564, 98-105, 2019 | 141 | 2019 |
| From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets M Sadia, A Isreb, I Abbadi, M Isreb, D Aziz, A Selo, P Timmins, MA Alhnan European Journal of Pharmaceutical Sciences 123, 484-494, 2018 | 111 | 2018 |
| Additive manufacturing of a Point‐of‐Care “Polypill:” Fabrication of concept capsules of complex geometry with bespoke release against cardiovascular disease BC Pereira, A Isreb, M Isreb, RT Forbes, EF Oga, MA Alhnan Advanced healthcare materials 9 (13), 2000236, 2020 | 62 | 2020 |
| Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells Y Haggag, B Abu Ras, Y El-Tanani, MM Tambuwala, P McCarron, M Isreb, ... Expert opinion on drug delivery 17 (11), 1655-1669, 2020 | 38 | 2020 |
| Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation SMH Shah, F Ullah, S Khan, SMM Shah, M de Matas, Z Hussain, ... Drug design, development and therapy, 3837-3850, 2016 | 38 | 2016 |
| Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals M Kuźmińska, BC Pereira, R Habashy, M Peak, M Isreb, TD Gough, ... International Journal of Pharmaceutics 598, 120305, 2021 | 36 | 2021 |
| Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer YA Haggag, M Yasser, MM Tambuwala, SS El Tokhy, M Isreb, AA Donia International Journal of Pharmaceutics 600, 120532, 2021 | 32 | 2021 |
| Novel ran-RCC1 inhibitory peptide-loaded nanoparticles have anti-cancer efficacy in vitro and in vivo YA Haggag, KB Matchett, RA Falconer, M Isreb, J Jones, A Faheem, ... Cancers 11 (2), 222, 2019 | 29 | 2019 |
| In-process rheometry as a PAT tool for hot melt extrusion AL Kelly, T Gough, M Isreb, R Dhumal, JW Jones, S Nicholson, AB Dennis, ... Drug development and industrial pharmacy 44 (4), 670-676, 2018 | 19 | 2018 |
| Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector J Khan, S Bashir, MA Khan, MA Mohammad, M Isreb Drug Design, Development and Therapy, 2617-2626, 2018 | 16 | 2018 |
| DNA Damage in Healthy Individuals and Respiratory Patients after Treating Whole Blood In vitro with the Bulk and Nano Forms of NSAIDs M Najafzadeh, C Normington, BK Jacob, M Isreb, RC Gopalan, ... Frontiers in molecular biosciences 3, 50, 2016 | 16 | 2016 |
| Efficient design to fabricate smart Lumefantrine nanocrystals using DENA® particle engineering technology: characterisation, in vitro and in vivo antimalarial evaluation and … SMH Shah, SMM Shah, S Khan, F Ullah, SWA Shah, M Ghias, M Shahid, ... Journal of Drug Delivery Science and Technology 61, 102228, 2021 | 11 | 2021 |
| ROS-induced oxidative damage in lymphocytes ex vivo/in vitro from healthy individuals and MGUS patients: protection by myricetin bulk and nanoforms S Akhtar, M Najafzadeh, M Isreb, L Newton, RC Gopalan, D Anderson Archives of toxicology 94, 1229-1239, 2020 | 11 | 2020 |
| An in vitro investigation into the protective and genotoxic effects of myricetin bulk and nano forms in lymphocytes of MGUS patients and healthy individuals S Akhtar, M Najafzadeh, M Isreb, L Newton, RC Gopalan, D Anderson Toxicology letters 327, 33-40, 2020 | 10 | 2020 |
| Anticancer potential of myricetin bulk and nano forms in vitro in lymphocytes from myeloma patients S Akhtar, M Najafzadeh, M Isreb, L Newton, RC Gopalan, D Anderson Archives of Toxicology 95, 337-343, 2021 | 8 | 2021 |
| Ex vivo/in vitro effects of aspirin and ibuprofen, bulk and nano forms, in peripheral lymphocytes of prostate cancer patients and healthy individuals A Guma, S Akhtar, M Najafzadeh, M Isreb, A Baumgartner, D Anderson Mutation Research/Genetic Toxicology and Environmental Mutagenesis 861, 503306, 2021 | 7 | 2021 |
| Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer M Alhawamdeh, M Isreb, A Aziz, BK Jacob, D Anderson, M Najafzadeh ERJ Open Research 7 (3), 2021 | 6 | 2021 |
| Ex vivo/in vitro protective effect of myricetin bulk and nano-forms on PhIP-induced DNA damage in lymphocytes from healthy individuals and pre-cancerous MGUS patients S Akhtar, M Najafzadeh, M Isreb, L Newton, RC Gopalan, D Anderson Archives of Toxicology 94, 2349-2357, 2020 | 6 | 2020 |
